About Dianox

Dianox is a founder-led biotech startup with an AI drug discovery platform for targeting undruggable proteins with DNA & RNA. Big opportunity as 85% of proteins are undruggable with small molecules and unreachable by antibodies. Our platform consists of the world's most powerful drug library and proprietary Deep Learning models that enable us to generate novel DNA & RNA drugs for efficient delivery to previously undruggable proteins. We can accelerate drug discovery in oncology, dermatology an

Company Highlights
Year Founded

2019

icon-altEmployees

13

Location (HQ)

DNK

Since Last Funding

2 years 1 month

Monthly Website Visitors

1.1K

Last Funding Round

Non Equity Assistance

icon-altYoY Headcount Growth

29.7%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Pharmaceutical

Artificial Intelligence (AI)

Therapeutics

Life Science